Fabrazyme® (agalsidase beta) ERT Treatment for Fabry Disease

Description: Discover Fabrazyme® (agalsidase beta), the only ERT (enzyme replacement therapy) indicated for patients 2 years and older with Fabry disease. See website for Important Safety Information & Full Prescribing Information including Boxed WARNING.

Health Conditions and Diseases Nutritional and Metabolic Disorders Cholesterol and Other Fats Fabry's 网站

2024年11月18日

返回